Form D · Biotechnology
INHIBITEX, INC.
Alpharetta, GA · CIK 0001274913
Offering snapshot reported Nov 9, 2009 · SEC filing
- Reported sold
- $23M Offering amount: $23M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2009 | Initial | $23,000,000 | No comparison | 12 | SEC filing |
| Sep 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.2M
- Finders' fees
- $0
- Form D file number
- 021-61535
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MTS Securities, LLC | 104059 |
Source: Form D, filed Nov 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| M. James Barrett | Director |
| Gabriele M. Cerrone | Director |
| Michael Henos | Director |
| Geoffrey W. Henson | Executive |
| Chris Mc Guigan | Director |
| Russell M. Medord | Director |
| Joseph M. Patti | Executive |
| Russell H. Plumb | Director, Executive |
| Marc L. Preminger | Director |
| A. Keith Willard | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9005 Westside Parkway
Alpharetta, GA, 30009
Alpharetta, GA, 30009